Clarification

The article "African American Genome Mappers Pledge To Carry On Despite Grant Rejection" (N. Sankaran, The Scientist, March 6, 1995, page 1) may have conveyed the impression that the proj-ect's grant application was rejected for funding by the National Institutes of Health. Following the three-year African American genome project (G-RAP) planning grant, the researchers submitted a synopsis of an intended follow-up study that was reviewed internally by the program staff of the National Center fo

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article "African American Genome Mappers Pledge To Carry On Despite Grant Rejection" (N. Sankaran, The Scientist, March 6, 1995, page 1) may have conveyed the impression that the proj-ect's grant application was rejected for funding by the National Institutes of Health. Following the three-year African American genome project (G-RAP) planning grant, the researchers submitted a synopsis of an intended follow-up study that was reviewed internally by the program staff of the National Center for Human Genome Research (NCHGR). It was determined that the follow-up proj-ect was too broad for the mission of NCHGR; hence, the grant application was not submitted to NIH for review.

The same article gave incorrect information regarding salaries for academic chemists. Within Ph.D.-granting chemistry departments, salaries are higher in private schools than in public schools. Within B.S.-granting departments, salaries are higher in public schools than in private schools. Additionally, the example of median salaries for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies